HLscience Co., Ltd. (KOSDAQ:239610)
South Korea · Delayed Price · Currency is KRW 6,840.00
-20.00 (-0.29%)
At close: May 29, 2026
HLscience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 13,761 | 16,706 | 17,664 | 25,587 | 52,758 | 104,375 |
Other Revenue | 0 | - | - | -0 | -0 | - |
| 13,761 | 16,706 | 17,664 | 25,587 | 52,758 | 104,375 | |
Revenue Growth (YoY) | -21.86% | -5.43% | -30.97% | -51.50% | -49.45% | -27.03% |
Cost of Revenue | 7,278 | 8,186 | 10,378 | 9,729 | 16,294 | 26,693 |
Gross Profit | 6,483 | 8,520 | 7,287 | 15,858 | 36,464 | 77,683 |
Selling, General & Admin | 14,750 | 17,449 | 14,942 | 18,260 | 34,845 | 61,217 |
Research & Development | 1,059 | 1,079 | 1,168 | 1,215 | 1,025 | 915.2 |
Amortization of Goodwill & Intangibles | 375.98 | 390.15 | 380.06 | 361.52 | 248.02 | 142.86 |
Other Operating Expenses | 89.23 | 90.63 | 58.57 | 77.8 | 109.53 | 135.65 |
Operating Expenses | 16,831 | 19,577 | 17,146 | 20,701 | 37,068 | 62,912 |
Operating Income | -10,347 | -11,057 | -9,859 | -4,843 | -603.66 | 14,771 |
Interest Expense | - | - | -14.83 | -0.02 | -0.23 | -1.34 |
Interest & Investment Income | 988.13 | 1,088 | 1,669 | 1,805 | 1,059 | 669.54 |
Currency Exchange Gain (Loss) | 29.9 | 9.61 | 9.71 | -0.06 | -6.6 | -19.77 |
Other Non Operating Income (Expenses) | 231.09 | 269.79 | -90.25 | 527.02 | 519.21 | 465.94 |
EBT Excluding Unusual Items | -9,098 | -9,690 | -8,286 | -2,511 | 967.36 | 15,885 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 8.02 |
Gain (Loss) on Sale of Assets | 31.2 | 31.2 | - | 4.8 | 1.23 | 42.35 |
Asset Writedown | -2,192 | -2,192 | -4.01 | - | - | - |
Pretax Income | -11,259 | -11,851 | -8,290 | -2,506 | 968.6 | 15,935 |
Income Tax Expense | 97.47 | 97.99 | -323.81 | -1,115 | -561.6 | 2,402 |
Earnings From Continuing Operations | -11,357 | -11,949 | -7,966 | -1,391 | 1,530 | 13,534 |
Minority Interest in Earnings | 61.89 | 31.64 | 89.68 | 14.91 | 62.17 | 5.74 |
Net Income | -11,295 | -11,917 | -7,877 | -1,376 | 1,592 | 13,539 |
Net Income to Common | -11,295 | -11,917 | -7,877 | -1,376 | 1,592 | 13,539 |
Net Income Growth | - | - | - | - | -88.24% | -31.07% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change (YoY) | 0.01% | 0.03% | -0.07% | -2.65% | 0.81% | 3.50% |
EPS (Basic) | -2218.18 | -2339.99 | -1547.00 | -270.13 | 304.25 | 2607.88 |
EPS (Diluted) | -2218.18 | -2339.99 | -1547.00 | -270.13 | 304.00 | 2607.88 |
EPS Growth | - | - | - | - | -88.34% | -33.40% |
Free Cash Flow | -6,752 | -7,512 | -4,734 | -4,177 | -7,390 | -7,687 |
Free Cash Flow Per Share | -1325.97 | -1474.96 | -929.81 | -819.94 | -1412.04 | -1480.55 |
Dividend Per Share | - | - | - | - | - | 400.000 |
Gross Margin | 47.11% | 51.00% | 41.25% | 61.98% | 69.12% | 74.43% |
Operating Margin | -75.19% | -66.19% | -55.82% | -18.93% | -1.14% | 14.15% |
Profit Margin | -82.08% | -71.34% | -44.59% | -5.38% | 3.02% | 12.97% |
Free Cash Flow Margin | -49.06% | -44.97% | -26.80% | -16.33% | -14.01% | -7.36% |
EBITDA | -7,881 | -8,456 | -7,300 | -2,435 | 1,049 | 15,580 |
EBITDA Margin | -57.27% | -50.62% | -41.33% | -9.52% | 1.99% | 14.93% |
D&A For EBITDA | 2,467 | 2,601 | 2,559 | 2,408 | 1,652 | 809.2 |
EBIT | -10,347 | -11,057 | -9,859 | -4,843 | -603.66 | 14,771 |
EBIT Margin | -75.19% | -66.19% | -55.82% | -18.93% | -1.14% | 14.15% |
Effective Tax Rate | - | - | - | - | - | 15.07% |
Advertising Expenses | - | 6,983 | 4,659 | 5,947 | 12,446 | 20,460 |